- Home
- VERB vs ADXN Comparison
VERB vs ADXN Comparison
Compare VERB & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- ADXN
- Stock Information
- Founded
- VERB 2014
- ADXN 2002
- Country
- VERB United States
- ADXN Switzerland
- Employees
- VERB N/A
- ADXN N/A
- Industry
- VERB Other Consumer Services
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- ADXN Health Care
- Exchange
- VERB Nasdaq
- ADXN Nasdaq
- Market Cap
- VERB 9.6M
- ADXN 10.1M
- IPO Year
- VERB N/A
- ADXN N/A
- Fundamental
- Price
- VERB $8.62
- ADXN $8.83
- Analyst Decision
- VERB Strong Buy
- ADXN Strong Buy
- Analyst Count
- VERB 1
- ADXN 1
- Target Price
- VERB $62.00
- ADXN $30.00
- AVG Volume (30 Days)
- VERB 23.4K
- ADXN 14.4K
- Earning Date
- VERB 08-13-2025
- ADXN 08-11-2025
- Dividend Yield
- VERB N/A
- ADXN N/A
- EPS Growth
- VERB N/A
- ADXN N/A
- EPS
- VERB N/A
- ADXN 0.10
- Revenue
- VERB $2,193,000.00
- ADXN $278,508.00
- Revenue This Year
- VERB $526.82
- ADXN $86.57
- Revenue Next Year
- VERB $45.45
- ADXN N/A
- P/E Ratio
- VERB N/A
- ADXN $0.78
- Revenue Growth
- VERB 3125.00
- ADXN N/A
- 52 Week Low
- VERB $3.81
- ADXN $6.51
- 52 Week High
- VERB $27.14
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- VERB 61.66
- ADXN 49.41
- Support Level
- VERB $7.00
- ADXN $8.78
- Resistance Level
- VERB $8.95
- ADXN $9.89
- Average True Range (ATR)
- VERB 0.62
- ADXN 0.67
- MACD
- VERB 0.13
- ADXN -0.03
- Stochastic Oscillator
- VERB 86.98
- ADXN 43.01
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.